The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 12, 2021
Filed:
May. 21, 2019
Applicant:
Eli Lilly and Company, Indianapolis, IN (US);
Inventors:
Guillermo S. Cortez, Indianapolis, IN (US);
Sajan Joseph, Carmel, IN (US);
Johnathan Alexander McLean, Indianapolis, IN (US);
William T. McMillen, Indianapolis, IN (US);
Michael John Rodriguez, Indianapolis, IN (US);
Gaiying Zhao, Carmel, IN (US);
Assignee:
Eli Lilly and Company, Indianapolis, IN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2005.12); A61P 35/00 (2005.12); A61K 31/506 (2005.12); A61K 31/519 (2005.12); A61K 39/395 (2005.12); C07D 495/04 (2005.12); C07D 498/08 (2005.12); C07D 513/04 (2005.12); C07K 16/28 (2005.12);
U.S. Cl.
CPC ...
A61K 31/5377 (2012.12); A61K 31/506 (2012.12); A61K 31/519 (2012.12); A61K 39/3955 (2012.12); A61P 35/00 (2017.12); C07D 495/04 (2012.12); C07D 498/08 (2012.12); C07D 513/04 (2012.12); C07K 16/2863 (2012.12);
Abstract
The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.